Ti Zhou
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 6
- Cancer, Lipids, and Metabolism 4
- Ophthalmology top 2%
- Molecular Biology top 10%
- Wnt/β-catenin signaling in development and cancer 6
- Angiogenesis and VEGF in Cancer 6
- Rehabilitation top 5%
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease 4
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
-
- Advanced Glycation End Products research 4
-
- Liver Disease Diagnosis and Treatment 4
- Journals
- Cell Death and Disease (5 papers)International Journal of Oncology (2 papers)Journal of Molecular Cell Biology (2 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Ti Zhou
66 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 433
- Ophthalmology 186
- Molecular Biology 997
- Rehabilitation 94
- Cell Biology 176
Countries citing papers authored by Ti Zhou
This map shows the geographic impact of Ti Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ti Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ti Zhou more than expected).
Fields of papers citing papers by Ti Zhou
This network shows the impact of papers produced by Ti Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ti Zhou. The network helps show where Ti Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ti Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 44 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 2 | |
| 12 | 2020 | 58 | |
| 13 | 2020 | 10 | |
| 14 | 2019 | 52 | |
| 15 | 2019 | 18 | |
| 16 | 2016 | 1 | |
| 17 | 2016 | 37 | |
| 18 | 2014 | 4 | |
| 19 | 2014 | 46 | |
| 20 | 2009 | 133 |
About Ti Zhou
Ti Zhou is a scholar working on Cancer Research, Cell Biology and Clinical Biochemistry, having authored 71 papers that have together received 1.8k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Advanced Glycation End Products research (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (433 citations), Ophthalmology (186 citations) and Molecular Biology (997 citations). Ti Zhou has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Guoquan Gao, Jian‐xing Ma, Xia Yang, Weiwei Qi, Zhonghan Yang, Ying Chen, Yang Hu, Kelu Zhou, Guoquan Gao and Zhiyu Dai. Their work appears in journals such as Cell Death and Disease, International Journal of Oncology, Journal of Molecular Cell Biology, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.